Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study ☆

By S. Mehta, S. Yusuf, R. Peters. 2002

829 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/4ec62212ec94ebf7ee01061ee18dade4f1ee5456

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Hani Jneid
2. Allan S. Jaffe
3. Massimo F. Piepoli
4. Stephen Burgess
5. S. Thompson

In Surgery

1. G. Moneta
2. Massimo F. Piepoli
3. Stephen Burgess
4. S. Thompson

Citations in the corpus

• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, neutral): “Arch Intern Med 2006;166:787–96.”
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Preferred options are eptifibatide or tirofiban (41, 149, 150).”
• Global vascular guidelines on the management of chronic limb-threatening ischemia (2019, background): “Clopidogrel is also effective as a single agent.(35,567) Use of DAPT after intervention has become standard in the treatment of CAD(134,568) and has migrated to other arenas of vascular intervention.”
• Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study* (2005, neutral): “Previous bypass surgery 6 (5) 7 (5) 0.”
• Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. (2002, positive): “Patients enrolled in CURE who underwent PCI and who were randomized to receive clopidogrel experienced a significantly lower incidence of adverse cardiovascular events at both 30 days and at a mean of 9 months, but pretreatment was given for a median of 10 days.(8) In CREDO, although pretreatment wi”
• Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. (2010, background): “DUAL ANTIPLATELET THERAPY with aspirin and clopidogrel reduces atherothrombotic complications in patients undergoing percutaneous coronary intervention (PCI) with stenting.(1,2) However, the individual response to dual antiplatelet therapy is not uniform, and consistent findings across multiple inve”
• 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016, methodology): “months of DAPT, as well as several meta-analyses (34-37) and an analysis by the ERC (30), did not find an”